Aldeyra Therapeutics, Inc. (ALDX)
1.55
-0.04
(-2.52%)
USD |
NASDAQ |
May 22, 16:00
1.54
-0.01
(-0.65%)
After-Hours: 20:00
Aldeyra Therapeutics EPS Diluted (Quarterly) : -0.0572 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| AbbVie, Inc. | 0.3861 |
| Rhythm Pharmaceuticals, Inc. | -0.8348 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| ADMA Biologics, Inc. | 0.1889 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.453M |
| Total Expenses (Quarterly) | 3.453M |
| Enterprise Value | 44.01M |
| Earnings Yield | -29.37% |
| Normalized Earnings Yield | -29.37 |